UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...
Taylor Tepper covered banking, investing and pretty much everything else in personal finance for more than a decade, with his work appearing in the New York Times, Fortune and MONEY magazine, as well ...
President Donald Trump’s approval rating hit a new low point for his second term in the latest survey released Wednesday—hours after he claimed he has the “highest numbers I ever had.” President ...
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback